Literature DB >> 6651378

Intraaortic balloon pump morbidity: a comparative analysis of risk factors between percutaneous and surgical techniques.

D M Shahian, W B Neptune, F H Ellis, P R Maggs.   

Abstract

We reviewed our concurrent experience with percutaneous insertion versus surgical placement of the intraaortic balloon pump over a two-year period both to compare morbidity and to provide guidelines for the choice of method in particular patient groups and clinical settings. The effects on morbidity of sex, age, emergency placement, coexisting peripheral vascular disease, and duration of counterpulsation were determined. Sex was a highly significant factor, with low complication rates (3/29 or 10.3%) for percutaneous insertion in men and an inordinately high morbidity (12/17 or 70.6%) in women (Fisher exact test: p = 4.611 X 10(-5)). This difference may be due to the smaller size of the femoral artery in women. We conclude that percutaneous insertion is the preferred technique for most men but that direct exposure of the femoral artery should be employed in women. Given the serious morbidity encountered with each technique, there is no justification to broaden the indications for intraaortic balloon counterpulsation.

Entities:  

Mesh:

Year:  1983        PMID: 6651378     DOI: 10.1016/s0003-4975(10)60273-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Intra-aortic balloon pumping: seven years' experience.

Authors:  W T Vigneswaran; I J Reece; K G Davidson
Journal:  Thorax       Date:  1985-11       Impact factor: 9.139

2.  Vascular complications associated with the use of intraaortic balloon pumping.

Authors:  P M Sanfelippo; N H Baker; H G Ewy; P J Moore; J W Thomas; G J Brahos; R F McVicker
Journal:  Tex Heart Inst J       Date:  1987-06

Review 3.  Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump.

Authors:  Haralabos Parissis; Alan Soo; Bassel Al-Alao
Journal:  J Cardiothorac Surg       Date:  2011-11-02       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.